Share-based Payment Arrangement, Expense of TENAX THERAPEUTICS, INC. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
TENAX THERAPEUTICS, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • TENAX THERAPEUTICS, INC. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $4,800,000, a 397% increase year-over-year.
  • TENAX THERAPEUTICS, INC. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $18,800,000, a 1780% increase year-over-year.
  • TENAX THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2025 was $18,800,000, a 1780% increase from 2024.
  • TENAX THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2024 was $1,000,000, a 762% increase from 2023.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

TENAX THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $18,800,000 $4,800,000 +$3,835,000 +397% 01 Oct 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
Q3 2025 $14,965,000 $5,500,000 +$5,491,000 +61011% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $9,474,000 $4,500,000 +$4,490,000 +44900% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $4,984,000 $4,000,000 +$3,984,000 +24900% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $1,000,000 $965,000 01 Oct 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
Q3 2024 $9,000 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $10,000 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 $16,000 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1

TENAX THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $18,800,000 +$17,800,000 +1780% 01 Jan 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
2024 $1,000,000 +$884,000 +762% 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
2023 $116,000 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.